APA (7th ed.) Citation

Cui, Y., Xu, J., Wen, J., Peng, J., Ren, J., Liu, A., . . . Liu, A. (2026). Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancer. Cancer Biology & Medicine, 23(6), 865. https://doi.org/10.20892/j.issn.2095-3941.2025.0589

Chicago Style (17th ed.) Citation

Cui, Yuzhen, Jingdong Xu, Junxu Wen, Jianfeng Peng, Jiangao Ren, Ailing Liu, Xiangjiao Meng, Zhaoqin Huang, and Anwen Liu. "Opportunities and Challenges of Immunotherapy for Patients with Resectable and Potentially Resectable Stage III Non-small Cell Lung Cancer." Cancer Biology & Medicine 23, no. 6 (2026): 865. https://doi.org/10.20892/j.issn.2095-3941.2025.0589.

MLA (9th ed.) Citation

Cui, Yuzhen, et al. "Opportunities and Challenges of Immunotherapy for Patients with Resectable and Potentially Resectable Stage III Non-small Cell Lung Cancer." Cancer Biology & Medicine, vol. 23, no. 6, 2026, p. 865, https://doi.org/10.20892/j.issn.2095-3941.2025.0589.